GSK2606414
| CAS No. | 1337531-36-8 | Cat. No. | BCP06992 |
| Name | GSK2606414 | ||
| Synonyms | GSK 2606414; GSK-2606414; | ||
| Formula | C24H20F3N5O | M. Wt | 451.44 |
| Description | GSK2606414 is an orally available, potent, and selective PERK inhibitor. Compound 38 inhibits PERK activation in cells and inhibits the growth of a human tumor xenograft in mice. Protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK) is activated in response to a variety of endoplasmic reticulum stresses implicated in numerous disease states. It is implicated that PERK plays an important role in tumorigenesis and cancer cell survival. | ||
| Pathways | Cell Cycle/DNA Damage | ||
| Targets | PERK | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.